Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-74,986
Closed -$3.69M 115
2020
Q1
$3.69M Buy
74,986
+16,395
+28% +$1.29M 2.74% 20
2019
Q4
$5.56M Sell
58,591
-12,770
-18% -$1.17M 3.11% 11
2019
Q3
$6.24M Sell
71,361
-449
-0.6% -$37.5K 3.6% 4
2019
Q2
$5.8M Sell
71,810
-16,035
-18% -$1.27M 3.16% 16
2019
Q1
$6.98M Sell
87,845
-13,540
-13% -$1.04M 3.2% 12
2018
Q4
$6.24M Sell
101,385
-18,490
-15% -$1.34M 2.98% 16
2018
Q3
$10.1M Sell
119,875
-6,210
-5% -$567K 2.99% 19
2018
Q2
$11.6M Sell
126,085
-78,970
-39% -$7.36M 3.41% 3
2018
Q1
$17.4M Sell
205,055
-41,595
-17% -$3.78M 3.46% 5
2017
Q4
$20.9M Buy
246,650
+32,100
+15% +$3.06M 3.55% 3
2017
Q3
$21.1M Buy
+214,550
New +$20.2M 3.04% 12

Other funds holding APTV

Stralem & Co's APTV Position: Q2 2020 in Review

Stralem & Co sold out of Aptiv (APTV) in Q2 2020, closing a stake of 74,986 shares — an estimated $3.69M sold.

Stralem & Co first reported a position in APTV in Q3 2017 and held it in 11 quarters. The position peaked at $21.1M in Q3 2017. 573 funds tracked by Wall St. Rank hold APTV as of Q2 2020.

  • Stralem & Co reported no remaining Aptiv position as of Q2 2020 after selling out during the quarter.
  • Stralem & Co sold 74,986 Aptiv shares in Q2 2020, an estimated $3.69M.
  • Stralem & Co first reported a position in Aptiv in Q3 2017 and held it in 11 quarters.
  • Stralem & Co's Aptiv position peaked at $21.1M in Q3 2017.
  • 573 funds tracked by Wall St. Rank held Aptiv as of Q2 2020.

Based on Stralem & Co's 13F filing for Q2 2020, filed 20 Jul 2020.